In this cohort of ART-naïve adult patients, patients prescribed a NVP-based regimen were much more likely to experience virologic failure within the first 12 months on treatment compared to patients initiated onto an EFV-based regimen, even after adjustment for age, sex, baseline anaemia and baseline CD4 count. This evidence concerns the gene CD4 and anemia (phenotype).